| CYM 2503 |
(9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氢喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 环己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯 |
1308833-36-4 |
| IPI3063 |
化合物IPI-3063 |
1425043-73-7 |
| F1063-0967 |
613225-56-2 |
613225-56-2 |
| BMS-935177 |
1231889-53-4 |
1231889-53-4 |
| Selective PI3Kδ Inhibitor 1 |
SELECTIVE PI3KΔ INHIBITOR 1;COMPOUND 7N |
2088525-31-7 |
| (+)-5-(4-amino-3-methylphenyl)-7-(2-thiazolyl)-8,9-dihydro-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine |
(+)-5-(4-AMINO-3-METHYLPHENYL)-7-(2-THIAZOLYL)-8,9-DIHYDRO-7H-1,3-DIOXOLO-[4,5-H][2,3]BENZODIAZEPINE |
923271-87-8 |
| GC7 Sulfate |
DHPS抑制剂 |
150417-90-6 |
| SAR405 R enantiomer |
1946010-79-2 |
1946010-79-2 |
| ML349 |
890819-86-0 |
890819-86-0 |
| PDD 00017273 |
1945950-21-9 |
1945950-21-9 |
| Protein kinase inhibitors 1 |
1365986-44-2 |
1365986-44-2 |
| LAU159 |
LAU159 |
2055050-87-6 |
| Ensartinib dihydrochloride |
2137030-98-7 |
2137030-98-7 |
| gsk2200150a |
1443138-53-1 |
1443138-53-1 |
| PKG drug G1 |
374703-78-3 |
374703-78-3 |
| JNJ-38877605 |
JNJ-38877618 |
943540-74-7 |
| incb057643 |
incb057643 |
1820889-23-3 |
| ONO-8590580 |
CS-2894 |
1802661-73-9 |
| Allosteric WNK Kinase Inhibitor , |
ALLOSTERIC WNK KINASE INHIBITOR |
2123489-30-3 |
| TP0427736 |
TP0427736 HCL |
864374-00-5 |
